Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NVAX

Novavax Inc

Apr 28 • 04:00PM ET

7.92

-0.15 -1.86 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: MRNA BNTX PFE JNJ AZN-D GSK SNY INO NVCR VIR

| Held by: XBI VTI VB IWM VBK VXF IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	3.33	EPS (ttm)	2.38	Insider Own	4.92%	Shs Outstand	162.58M	Perf Week	-6.71%
Market Cap	1.29B	Forward P/E	-	EPS next Y	-0.24	Insider Trans	0.00%	Shs Float	154.93M	Perf Month	-6.27%
Enterprise Value	822.54M	PEG	-	EPS next Q	-0.23	Inst Own	68.15%	Short Float	29.91%	Perf Quarter	-19.35%
Income	440.30M	P/S	1.15	EPS this Y	-115.50%	Inst Trans	7.53%	Short Ratio	11.16	Perf Half Y	-7.04%
Sales	1.12B	P/B	-	EPS next Y	38.73%	ROA	31.61%	Short Interest	46.34M	Perf YTD	17.86%
Book/sh	-0.79	P/C	1.73	EPS next 5Y	-	ROE	-	52W High	11.97 -33.83%	Perf Year	18.12%
Cash/sh	4.58	P/FCF	-	EPS past 3/5Y	- -	ROIC	319.27%	52W Low	5.80 36.55%	Perf 3Y	3.26%
Dividend Est.	-	EV/EBITDA	1.39	Sales past 3/5Y	-17.24% 18.76%	Gross Margin	93.50%	Volatility	3.95% 4.44%	Perf 5Y	-96.76%
Dividend TTM	-	EV/Sales	0.73	EPS Y/Y TTM	323.82%	Oper. Margin	50.14%	ATR (14)	0.41	Perf 10Y	-92.73%
Dividend Ex-Date	Dec 13, 2007	Quick Ratio	2.10	Sales Y/Y TTM	64.69%	Profit Margin	39.19%	RSI (14)	38.28	Recom	2.44
Dividend Gr. 3/5Y	- -	Current Ratio	2.13	EPS Q/Q	120.98%	SMA20	-4.31%	Beta	2.40	Target Price	14.00
Payout	0.00%	Debt/Eq	-	Sales Q/Q	66.61%	SMA50	-13.33%	Rel Volume	0.79	Prev Close	8.07
Employees	749	LT Debt/Eq	-	Earnings	Feb 26 BMO	SMA200	-3.18%	Avg Volume	4.15M	Price	7.92
IPO	Dec 05, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	122.69% 63.77%	Trades		Volume	3,282,284	Change	-1.86%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)